Navigation Links
Hill-Rom Announces Preliminary Fiscal 2013 Third Quarter Results and Search for New CFO; Adjusted Earnings Per Share Expected to be in Line with Guidance

BATESVILLE, Ind., July 17, 2013 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that it has begun an external search for a new Chief Financial Officer to replace its current CFO, Mark Guinan, who has resigned to accept a position with another company.  Michael Macek, Hill-Rom's Vice President and Treasurer, will act as interim CFO until the search is complete.

(Logo: )

"Mark has been a strong leader and valued contributor to Hill-Rom throughout his tenure," said John Greisch, President and CEO. "I would like to personally thank him for his service and wish him every future success."

Greisch continued, "We have engaged an executive search consultant to conduct the process for identifying Mark's successor as our Chief Financial Officer, and will provide an update on the process when appropriate."

Additionally, Hill-Rom announced preliminary unaudited financial results for its fiscal third quarter ended June 30, 2013.  Hill-Rom expects to report adjusted earnings of approximately $0.49 per share, within the range of its previous guidance.  Revenue is expected to be approximately $424 million, an increase of 4 percent compared to last year.  

As previously announced, Hill-Rom will host a conference call and webcast Thursday, July 25, 2013, from 8:00 a.m. - 9:00 a.m. ET to discuss more fully its third quarter results.

Earnings Webcast:  To join the live webcast with audio on July 25, 2013, go to  The webcast slide deck will be posted to the Hill-Rom website prior to the webcast. 

Earnings Conference Call Audio Only Dial-in information:  To participate in the live conference call, dial 877-304-8969 domestic callers / 631-291-4543 international callers.  Confirmation Code for both: 97174013.  Callers will need to provide their name, company affiliation and telephone number to the conference operator. 

A recording of the webcast/call audio will be available for telephone replay through July 31, 2013, domestically at 855-859-2056 and internationally at 404-537-3406. For the replay, callers will need to use confirmation code 97174013. If you are unable to listen to the live webcast or the telephone replay, the webcast will be archived at

Discussion of Adjusted Financial Measures

Hill-Rom Holdings, Inc. routinely provides earnings per share results and guidance on an adjusted basis because the Company's management believes that the presentation provides useful information to investors.  These measures exclude strategic developments, special charges or other unusual events.  Such items may be highly variable, difficult to predict and of a size that sometimes have substantial impact on the Company's reported operations for a period. Often, prospective quantification of such items is not feasible.  Management uses these measures internally for planning, forecasting and evaluating the performance of the business. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.


Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions.  Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom...enhancing outcomes for patients and their caregivers.

Disclosure Regarding Forward-Looking Statements

Certain statements herein contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements. For a more in depth discussion of factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's previously filed most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation to update or revise any forward-looking statements.

SOURCE Hill-Rom Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hill-Rom to Participate in the Goldman Sachs 34th Annual Global Healthcare Conference
2. Hill-Rom Increases Third Quarter 2013 Dividend
3. Hill-Rom to Participate in the 38th Annual Deutsche Bank Health Care Conference
4. Hill-Rom Receives FDA 510(k) Clearance to Market MetaNeb 4.0 Airway Clearance System
5. Hill-Rom Reports Fiscal Second Quarter Adjusted Earnings Per Share In Line With Expectations; Provides Third Quarter And Updated Full-Year Financial Outlook
6. Hill-Rom Holdings, Inc. to Host Investor Conference May 7
7. Hill-Rom Holdings, Inc. Hosts Fiscal 2013 Second Quarter Earnings Conference Call and Webcast
8. Hill-Rom Elects William H. Kucheman to its Board of Directors
9. Hill-Rom Announces Second Quarter 2013 Dividend
10. Hill-Rom to Participate in the 2013 Citi Global Healthcare Conference
11. Hill-Rom Reports Fiscal First Quarter Results; Updates 2013 Financial Outlook For R&D Tax Credit Reinstatement
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015 Nevro Corp. (NYSE: ... providing innovative evidence-based solutions for the treatment of chronic pain, ... at the U.S. Patent and Trademark Office (USPTO) has denied ... Patent No. 8,359,102 (the ,102 patent).  ... unit of Boston Scientific Corporation filed two petitions challenging the ...
(Date:11/30/2015)... , Nov. 30, 2015 ... the "Orphan Drugs Market 2015-2019" report ... has announced the addition of the "Orphan ... --> Research and Markets ( ... "Orphan Drugs Market 2015-2019" report to their ...
(Date:11/30/2015)... global cell culture market is expected ... bn by 2022 at a CAGR of 7.1% therein. --> ... its 2013 value of US$6.1 bn to US$11.3 bn by 2022 ... Research has announced the release of a new market research study, ... ,Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... , ... According to an article published November 13th by People ... to show her Instagram followers that the praise that they were bestowing on her ... she didn’t “want to mislead any mommy's who just had babies and are stressing,” ...
(Date:11/30/2015)... ... ... A record crowd gathered at the Pennsylvania Biotech Center of Bucks County ... Institute. , The institute, which is the research arm of the Hepatitis B Foundation, ... conference, which focused on ways companies can work to reduce the cost and improve ...
(Date:11/30/2015)... ... November 30, 2015 , ... At Grand Dental PC, their ... setting. , When you have dental problems, you need to turn to a dentist ... diagnose and treat your needs, a friendly dentist who counsels you on the best ...
(Date:11/30/2015)... ... , ... Newly reviewed and approved “NJ Top Dentist”, Dr. Eugene Isola III, ... Medicine in 1935. His father graduated from NYU School of Dentistry in 1965. ... as their commitment and passion to the Practice of Dentistry. Continuing the family ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Foundation ... cancer education and prevention—is joining forces with the award-winning creator and writer of ... on December 7, 2015 at the Union League of Philadelphia. , The ...
Breaking Medicine News(10 mins):